Cytek Biosciences, Inc. provided revenue guidance for the fiscal year 2022. Cytek Biosciences expects full year 2022 revenue to be in the range of $160 million to $168 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.68 USD | +1.07% | -5.49% | -37.72% |
Jun. 12 | Cytek Biosciences to Seek M&A | CI |
Jun. 12 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.72% | 738M | |
+6.69% | 218B | |
+10.01% | 189B | |
+27.82% | 151B | |
+32.06% | 113B | |
-0.15% | 64.02B | |
+13.95% | 52.6B | |
+1.85% | 49.85B | |
-5.58% | 37.89B | |
+0.45% | 34.92B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences, Inc. Provides Revenue Guidance for the Fiscal Year 2022